Parallax Volatility Advisers
IOVA icon

Parallax Volatility Advisers’s Iovance Biotherapeutics IOVA Stock Holding History

Parallax Volatility Advisers’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,977
Closed -$139K – 2073
2023
Q4 		$97.4K Buy
+11,977
New +$62.7K ﹤0.01% 1873
2021
Q2 		– Sell
-2,196
Closed -$57.1K – 3255
2021
Q1 		$70K Buy
2,196
+1,227
+127% +$50.9K ﹤0.01% 2900
2020
Q4 		$45K Sell
969
-8,176
-89% -$325K ﹤0.01% 3072
2020
Q3 		$301K Buy
+9,145
New +$280K ﹤0.01% 2402
2020
Q1 		– Sell
-2,637
Closed -$73K – 2586
2019
Q4 		$73K Buy
+2,637
New +$60K ﹤0.01% 2182
2019
Q3 		– Sell
-10
Closed – – 2886
2019
Q2 		$0 Buy
+10
New +$151 ﹤0.01% 3150
2019
Q1 		– Sell
-174
Closed -$2K – 3381
2018
Q4 		$2K Sell
174
-6,711
-97% -$64.7K ﹤0.01% 2698
2018
Q3 		$77K Buy
+6,885
New +$97.7K ﹤0.01% 1754
2018
Q1 		– Sell
-9,408
Closed -$75K – 3224
2017
Q4 		$75K Buy
+9,408
New +$75.5K ﹤0.01% 2968

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Parallax Volatility Advisers's IOVA Position: Q1 2024 in Review

Parallax Volatility Advisers sold out of Iovance Biotherapeutics (IOVA) in Q1 2024, closing a stake of 11,977 shares — an estimated $139K sold.

Parallax Volatility Advisers first reported a position in IOVA in Q4 2017 and held it in 9 quarters. The position peaked at $301K in Q3 2020. 273 funds tracked by Wall St. Rank hold IOVA as of Q1 2024.

  • Parallax Volatility Advisers reported no remaining Iovance Biotherapeutics position as of Q1 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 11,977 Iovance Biotherapeutics shares in Q1 2024, an estimated $139K.
  • Parallax Volatility Advisers first reported a position in Iovance Biotherapeutics in Q4 2017 and held it in 9 quarters.
  • Parallax Volatility Advisers's Iovance Biotherapeutics position peaked at $301K in Q3 2020.
  • 273 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2024.

Based on Parallax Volatility Advisers's 13F filing for Q1 2024, filed 15 May 2024.